Ideaya

IDEAYA Biosciences stock slides after pricing securities offering to raise $263 million

IDEAYA Biosciences (NASDAQ:IDYA) said Monday it has priced an underwritten public offering of shares and warrants to raise about $263 million. The company plans to offer 7.3 million shares of common stock at $35 per share and pre-funded warrants to purchase 285,715 shares of common stock at $34.9999 a piece.Continue Reading

Ideaya stock jumps after positive study data from cancer study (NASDAQ:IDYA)

In: Finance

Ideaya Biosciences (NASDAQ:IDYA) shares jumped as much as 23% premarket on Monday after the oncology company reported positive interim data from an expansion dose cohort of a mid-stage trial of IDE397. IDE397 is a potential first-in-class MAT2A (methionine adenosyltransferase 2 alpha) inhibitor, that is being advanced as a monotherapy agentContinue Reading

IDEAYA Biosciences stock slides after pricing securities offering to raise $263 million

Ideaya stock jumps after positive study data from cancer study (NASDAQ:IDYA)

How Rocket Companies modernized their data science solution on AWS | Amazon Web Services

AWS and DXC collaborate to deliver customizable, near real-time voice-to-voice translation capabilities for Amazon Connect | Amazon Web Services